Literature DB >> 15951047

An autoradiographic study of [(18)F]FDG uptake to islets of Langerhans in NOD mouse.

Teemu Kalliokoski1, Olli Simell, Merja Haaparanta, Tapio Viljanen, Olof Solin, Juhani Knuuti, Pirjo Nuutila.   

Abstract

To evaluate the potential of in vivo imaging of accumulation of lymphocytes to islets of Langerhans (insulitis), we compared 2-[(18)F]fluoro-2-deoxy-d-glucose ([(18)F]FDG) uptake in the pancreas and pancreatic islets of healthy BALB/c mice, phenotypically healthy NOD mice with insulitis and diabetic NOD mice. [(18)F]FDG was injected i.v. to 14 female BALB/c mice (age 13+/-3 weeks, plasma glucose 8+/-2 mmol/l) and 21 age-matched female NOD mice (plasma glucose 8+/-4 mmol/l, p=0.06). The mice were killed 90-min post injection and distribution of radioactivity was analysed using digital autoradiography. There was no correlation of plasma glucose concentration with the [(18)F]FDG uptake values. Uptake of radioactivity in NOD mice to the islets affected by insulitis was up to 2.3 times higher (p=0.001) than that to unaffected islets in the same pancreas. Uptake to NOD islets with insulitis was also clearly enhanced (1.0-2.3 times higher) compared to the islets in the BALB/c mice. In conclusion, NOD mouse islets with insulitis accumulate [(18)F]FDG markedly more than islets without insulitis or BALB/c islets. However, the relatively small difference in the [(18)F]FDG intensity between healthy and diseased islets, combined with the limited resolution ability of the positron emission tomography (PET), probably prevent the use of [(18)F]FDG in PET studies aiming at in vivo documentation of onset and progression of insulitis and prediabetes in mouse and man.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951047     DOI: 10.1016/j.diabres.2005.04.008

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

Review 1.  Imaging the islet graft by positron emission tomography.

Authors:  Olof Eriksson; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-20       Impact factor: 9.236

2.  Beta-cell imaging: opportunities and limitations.

Authors:  Thomas C Kwee; Sandip Basu; Babak Saboury; Drew A Torigian; Ali Naji; Abass Alavi
Journal:  J Nucl Med       Date:  2011-02-14       Impact factor: 10.057

Review 3.  Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis.

Authors:  K Andralojc; M Srinivas; M Brom; L Joosten; I J M de Vries; D L Eizirik; O C Boerman; P Meda; M Gotthardt
Journal:  Diabetologia       Date:  2012-02-23       Impact factor: 10.122

4.  PET/MRI in infectious and inflammatory diseases: will it be a useful improvement?

Authors:  Andor W J M Glaudemans; Ana Maria Quintero; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05       Impact factor: 9.236

5.  Pancreatic 18F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls.

Authors:  Guido J Bakker; Manon C Vanbellinghen; Torsten P Scheithauer; C Bruce Verchere; Erik S Stroes; Nyanza K L M Timmers; Hilde Herrema; Max Nieuwdorp; Hein J Verberne; Daniël H van Raalte
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

Review 6.  Pancreatic islet blood flow and its measurement.

Authors:  Leif Jansson; Andreea Barbu; Birgitta Bodin; Carl Johan Drott; Daniel Espes; Xiang Gao; Liza Grapensparr; Örjan Källskog; Joey Lau; Hanna Liljebäck; Fredrik Palm; My Quach; Monica Sandberg; Victoria Strömberg; Sara Ullsten; Per-Ola Carlsson
Journal:  Ups J Med Sci       Date:  2016-04-28       Impact factor: 2.384

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.